tiprankstipranks
Starling Oncology Institute (STLN)
NASDAQ:STLN
US Market
Want to see STLN full AI Analyst Report?

Starling Oncology Institute (STLN) Financial Statements

211 Followers

Starling Oncology Institute Financial Overview

Starling Oncology Institute's market cap is currently $485.92M. The company's EPS TTM is $-0.35; its P/E ratio is -13.89; Starling Oncology Institute is scheduled to report earnings on August 6, 2026, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 502.73M$ 393.41M$ 324.24M$ 252.48M$ 203.00M
Gross Profit$ 76.44M$ 54.00M$ 59.57M$ 52.09M$ 40.85M
Operating Income$ -36.08M$ -60.12M$ -77.02M$ -81.95M$ -45.86M
EBITDA$ -42.52M$ -50.88M$ -54.28M$ -67.60M$ -42.04M
Net Income$ -60.61M$ -64.66M$ -83.07M$ 152.00K$ -10.93M
Balance Sheet
Cash & Short-Term Investments$ 33.56M$ 49.67M$ 82.86M$ 73.81M$ 114.30M
Total Assets$ 164.66M$ 172.72M$ 209.24M$ 261.67M$ 203.44M
Total Debt$ 103.69M$ 123.15M$ 119.67M$ 108.18M$ 183.00K
Net Debt$ 70.12M$ 73.48M$ 86.19M$ 94.17M$ -114.12M
Total Liabilities$ 180.38M$ 169.13M$ 152.22M$ 138.49M$ 99.28M
Stockholders' Equity$ -15.72M$ 3.59M$ 57.02M$ 123.17M$ 104.16M
Cash Flow
Free Cash Flow$ -27.79M$ -30.33M$ -40.88M$ -67.28M$ -35.73M
Operating Cash Flow$ -24.59M$ -26.54M$ -36.31M$ -61.76M$ -32.68M
Investing Cash Flow$ -3.07M$ 46.21M$ 62.64M$ -131.61M$ -12.15M
Financing Cash Flow$ 11.56M$ -3.49M$ -6.85M$ 92.21M$ 154.01M
Currency in USD

Starling Oncology Institute Earnings and Revenue History

Starling Oncology Institute Debt to Assets

Starling Oncology Institute Cash Flow

Starling Oncology Institute Forecast EPS vs Actual EPS